We have reported the existence of a crosstalk between oncogenic signaling pathways in breast tumor cells in humans and mice triggered by leptin, IL-1 and Notch (NILCO) critical to leptin-induced breast cancer promotion [31]. This evidence concerns the gene LEP and breast cancer.